Newborn Screening

Detecting a disease at an early stage can enable appropriate and timely medical intervention before more serious and sometimes irreversible health issues are caused.

 
About

Each year, an estimated 7.9 million babies worldwide are born with birth defects, many of which appear healthy at birth and come from families with no history of the disorder. Many affected babies are not identified until the appearance of severe and often irreversible symptoms later in life.

Detecting a disease at an early stage can enable appropriate and timely medical intervention before more serious and sometimes irreversible health issues are caused.

DIPBORN™ Newborn Genetic Screening Test determines a baby’s risk for 87 inherited disorders, as well as providing personalized genetic information on the likely response of 32 pediatric drugs.

The advantage of early insight
DIPLOIDE BLACK BOX 2020.png

DIPBORN is a very accurate test that analyzes your baby's DNA to detect more than 190 conditions* that can affect children before the age of 10.

 

It only detects conditions that can be treated † with medication, diet modification or other therapies.

 

Each DIPBORN report also includes an analysis of your child's response to more than 40 medications that may be prescribed during childhood, including common antibiotics. This test can help doctors customize the treatment for your child throughout his life.

 

*DIPBORN analyzes 166 genes to detect 193 genetic conditions.

† Always check with your child's pediatrician before taking any medical action or starting treatment based on the results of DIPBORN.

Results you can trust

DIPBORN was developed by a team of important clinical and molecular geneticists, pediatricians and scientists with experience in pediatric genetic conditions. This test was carefully designed to provide accurate and useful results, based on years of research and clinical experience in molecular diagnosis. DIIPBORN met strict criteria, including:

Analytical validity, or how accurately a test can detect a certain genetic change (or variant). All DNA samples for DIPBORN are analyzed in our CLIA-certified laboratory using advanced DNA sequencing technology that is> 95% accurate.

Clinical validity, or how well a genetic test can predict a certain disease. DIPBORN only detects highly penetrating genetic changes. This means that if someone is born with genetic changes evaluated by this test, there is a high probability (> 80%) of developing symptoms of the associated disease.

Clinical utility, or if a genetic test provides useful information that can help improve treatment options or other health care decisions. DIPBORN only detects conditions that can be treated * with medications, diet modification or other therapies.

*Always check with your child's pediatrician before taking any medical action or starting treatment based on the results of DIPBORN screening.

LOGO SMALL MINIMALISTIC 2020.png

EXPLORE

LEGAL

CONNECT WITH US

Facebook

Twitter

Instagram

YouTube

Linkedin

© 2020 by DIPLOIDE GENETICS CORPORATION INC.

Contact Us